+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
Respiratory Drug Delivery Market Report 2024-2034 - Product Thumbnail Image

Respiratory Drug Delivery Market Report 2024-2034

  • Report
  • January 2024
  • 348 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 500 Pages +
  • Global
From
Human Papillomavirus (HPV) Vaccine Market Report 2026 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 - Product Thumbnail Image

US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029

  • Report
  • September 2023
  • 230 Pages
  • United States
From
From
From
From
U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031 - Product Thumbnail Image

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

  • Drug Pipelines
  • February 2026
  • 3300 Pages
  • United States
From
From
From
Research Report on China's Levetiracetam Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Levetiracetam Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
Interleukin Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Interleukin Inhibitors - Global Strategic Business Report

  • Report
  • June 2026
  • 288 Pages
  • Global
From
TNF Inhibitors - Global Strategic Business Report - Product Thumbnail Image

TNF Inhibitors - Global Strategic Business Report

  • Report
  • June 2026
  • 191 Pages
  • Global
From
Loading Indicator